CRDL
Cardiol Therapeutics Inc - Ordinary Shares - Class A

5,667
Mkt Cap
$100M
Volume
407,024.00
52W High
$1.59
52W Low
$0.7709
PE Ratio
-3.34
CRDL Fundamentals
Price
$1.00
Prev Close
$1.04
Open
$1.04
50D MA
$1.06
Beta
1.26
Avg. Volume
404,077.95
EPS (Annual)
-$0.3741
P/B
12.73
Rev/Employee
$0.00
Loading...
Loading...
News
all
press releases
Cardiol Therapeutics Inc. (NASDAQ:CRDL) Given Average Recommendation of "Buy" by Brokerages
Shares of Cardiol Therapeutics Inc. (NASDAQ:CRDL - Get Free Report) have received a consensus rating of "Buy" from the five research firms that are covering the stock, MarketBeat reports. One...
MarketBeat·17h ago
News Placeholder
More News
News Placeholder
Cardiol Therapeutics (NASDAQ:CRDL) Receives "Buy" Rating from HC Wainwright
HC Wainwright reiterated a "buy" rating and set a $9.00 price objective on shares of Cardiol Therapeutics in a report on Monday...
MarketBeat·15d ago
News Placeholder
Cardiol Therapeutics (TSE:CRDL) Trading Down 7.9% - Here's Why
Cardiol Therapeutics (TSE:CRDL) Trading Down 7.9% - Should You Sell...
MarketBeat·15d ago
News Placeholder
Cardiol Therapeutics Inc. (NASDAQ:CRDL) Given Consensus Rating of "Buy" by Brokerages
Cardiol Therapeutics Inc. (NASDAQ:CRDL - Get Free Report) has received an average recommendation of "Buy" from the five analysts that are presently covering the stock, MarketBeat reports. One...
MarketBeat·25d ago
News Placeholder
Cardiol Therapeutics (TSE:CRDL) Trading Down 3.5% - What's Next?
Cardiol Therapeutics (TSE:CRDL) Stock Price Down 3.5% - Time to Sell...
MarketBeat·30d ago
News Placeholder
Cardiol Therapeutics (NASDAQ:CRDL) Issues Quarterly Earnings Results, Hits Expectations
Cardiol Therapeutics (NASDAQ:CRDL - Get Free Report) issued its earnings results on Thursday. The company reported ($0.09) EPS for the quarter, hitting the consensus estimate of ($0.09...
MarketBeat·1mo ago
News Placeholder
Zacks Industry Outlook Highlights Akebia Therapeutics, Ironwood Pharmaceuticals, Pyxis Oncology, Cardiol Therapeutics and Plus Therapeutics
Small-cap biotech momentum surges as AKBA, IRWD, PYXS, CRDL, and PSTV gain on pipeline progress and sector recovery.
Zacks·2mo ago
News Placeholder
5 Small Drug Stocks to Buy as the Industry Shows Some Recovery
Innovation is at its peak in the Zacks Medical-Drugs industry. AKBA, IRWD, PYXS, CRDL and PSTV may prove to be good additions to one's portfolio.
Zacks·2mo ago
<
...
1
>

Latest CRDL News

View

Advertisement|Remove ads.

Advertisement|Remove ads.